In the Media: highlights from Microbiology and Immunology July & August 2022
Our experts from the Dept of Microbiology & Immunology at the Peter Doherty Institute have been at the forefront of COVID-19 breakthrough research and media commentary. Catch up on the latest highlights here.
- Ashley Porter spoke to the Warrnambool Times about Omicron sub variants BA.4 and BA.5. The story was syndicated nationally.
- Axel Kallies and Carlson Tsui published a paper in Nature about their discovery of a new population of immune cells which are critical in maintaining the immune response against chronic infections and cancer. The discovery may explain why immunotherapy fails in some people and could lead to the development of more effective new therapies for cancer or severe viral infections. Axel was interviewed on ABC, on Channel 10 and by the Herald Sun.
- Jen Juno spoke with ABC News for an explainer on Omicron specific vaccines.
- Laura Mackay was a guest on The Immunology Podcast talking about tissue-resident T cells and her collaboration with Pfizer to identify and validate new targets for cancer therapy.
- Peter Doherty spoke with The Canberra Times about the Omicron variant, explaining why it has been able to spread so widely in the community. This article was syndicated nationally.
- Peter Doherty launched his memoir on ABC TV. He also talked to ABC Radio about his new book.
- Raissa Fonesca and Tom Burn published a paper in Nature Immunology which identified the molecular switch that allows TRM cells to reside in the epithelia, and showed this molecule could be deployed to enforce tissue residency in CD4+ T cells. The story was covered by Medical Xpress.
